Mirae Asset Global Investments Co. Ltd. Increases Stake in Tempus AI, Inc. $TEM

Mirae Asset Global Investments Co. Ltd. grew its position in Tempus AI, Inc. (NASDAQ:TEM) by 1,459.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 101,276 shares of the company’s stock after buying an additional 94,783 shares during the period. Mirae Asset Global Investments Co. Ltd. owned approximately 0.06% of Tempus AI worth $8,174,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Cranbrook Wealth Management LLC purchased a new position in Tempus AI in the 3rd quarter worth approximately $25,000. GAMMA Investing LLC bought a new stake in shares of Tempus AI in the 3rd quarter worth $28,000. Concord Wealth Partners raised its stake in shares of Tempus AI by 308.0% in the second quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after purchasing an additional 308 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock valued at $29,000 after purchasing an additional 450 shares in the last quarter. Finally, SouthState Corp lifted its holdings in shares of Tempus AI by 3,761.5% during the second quarter. SouthState Corp now owns 502 shares of the company’s stock valued at $32,000 after purchasing an additional 489 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Insiders Place Their Bets

In related news, CFO James William Rogers sold 19,966 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $73.20, for a total value of $1,461,511.20. Following the transaction, the chief financial officer directly owned 111,250 shares of the company’s stock, valued at approximately $8,143,500. The trade was a 15.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction on Wednesday, January 28th. The stock was sold at an average price of $65.56, for a total transaction of $10,899,350.00. Following the completion of the transaction, the chief executive officer directly owned 8,941,533 shares in the company, valued at $586,206,903.48. This trade represents a 1.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 766,582 shares of company stock worth $52,454,299 in the last three months. 26.27% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on TEM. JPMorgan Chase & Co. decreased their target price on Tempus AI from $85.00 to $80.00 and set a “neutral” rating for the company in a research report on Monday, December 15th. BTIG Research boosted their price objective on shares of Tempus AI from $96.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a report on Thursday, January 22nd. Morgan Stanley boosted their target price on shares of Tempus AI from $80.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, December 1st. Finally, Needham & Company LLC increased their price target on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Six research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Tempus AI currently has a consensus rating of “Hold” and a consensus target price of $87.20.

Tempus AI Stock Down 5.8%

NASDAQ TEM opened at $59.82 on Friday. Tempus AI, Inc. has a 52 week low of $36.22 and a 52 week high of $104.32. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The company has a market capitalization of $10.64 billion, a P/E ratio of -50.27 and a beta of 5.22. The stock’s 50-day moving average price is $68.56 and its 200-day moving average price is $74.02.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.05. The business had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company’s revenue for the quarter was up 84.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.46) earnings per share. On average, equities research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.